Oct. 10, 2018 Price forecast | 2 weeks: 1.17% | 1 month: 3.82% | 3 months: 11.53% | Premium Forecast


OMED stock forecast

Our latest prediction for OncoMed Pharmaceuticals, Inc.'s stock price was made on the Oct. 10, 2018 when the stock price was at 2.04$.

In the short term (2weeks), OMED's stock price should outperform the market by 1.17%. During that period the price should oscillate between -9.27% and +16.11%.

In the medium term (3months), OMED's stock price should outperform the market by 11.53%. During that period the price should oscillate between -20.88% and +45.88%.


About OncoMed Pharmaceuticals, Inc.

Develops anti-cancer stem cell therapeutics

At the moment the company generates 55M USD in revenues.

On its last earning announcement, the company reported a profit of 0.16$ per share.

The book value per share is 1.13$

OncoMed Pharmaceuticals, Inc. website


Three months stock forecastOct. 10, 2018


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
55M - 3M 5.90% 6M 0.16 - - 38M 1.13 -43M -1M -44M